Multivariate regression analysis of the association between higher levels of CD62E+ microparticles and outcome.

*Hazard ratios were adjusted for all of the following: age; sex; presence of hypertension, diabetes, hyperlipidemia, smoking status, high cardioembolic risk, or known coronary artery disease; stroke etiology; and concomitant treatment with antiplatelet agents, warfarin, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta blockers, calcium channel blockers, diuretics, or statins.†Hospitalization was due to cardiovascular events, including recurrent angina, congestive heart failure, myocardial infarction, or stroke. CAD denotes coronary artery disease and CI denotes confidence interval.